Skip to main navigation Skip to search Skip to main content

Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk

  • Mignon T. van den Elzen*
  • , Harmieke van Os-Medendorp
  • , Heike Röckmann-Helmbach
  • , Els van Hoffen
  • , Ans F M Lebens
  • , Helma van Doorn
  • , Rob J B Klemans
  • , Carla A F M Bruijnzeel-Koomen
  • , C. Erik Hack
  • , Leonard Kaufman
  • , Anurag Relan
  • , André C. Knulst
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background Recombinant human C1 inhibitor (rhC1INH) for on-demand treatment of hereditary angioedema is purified from milk of transgenic rabbits. It contains low amounts (

Original languageEnglish
Pages (from-to)476-481.e1
JournalJournal of Allergy and Clinical Immunology
Volume138
Issue number2
DOIs
Publication statusPublished - 1 Aug 2016

Keywords

  • allergenicity
  • cow's milk allergy
  • Hereditary angioedema
  • intracutaneous test
  • intradermal testing
  • rabbit allergy
  • recombinant human C1 esterase inhibitor
  • skin prick test
  • subcutaneous administration
  • subcutaneous challenge

Fingerprint

Dive into the research topics of 'Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk'. Together they form a unique fingerprint.

Cite this